Drugmakers fear possible fallout of Tylenol snafu

Domestic drug firms are now under full alert to inspect the manufacturing, product management and quality control procedures on their medicinal products as the quality control (QC) team of Janssen Korea was at the center of the recent Tylenol scandal.

The Ministry of Food and Drug Safety (MFDS) completed its two-week special audit on Janssen Korea earlier this month, and ordered the company ...